April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves. 

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S. Food and Drug Administration (FDA) indication for treatment of de novo chronic total occlusion (CTO) lesions. The stent is also indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions of length ≤ 35 mm in native coronary arteries with reference vessel diameters of 2.25 - 4.2 mm. 

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., announced Tuesday the agency is pursuing a new framework in which to review artificial intelligence (AI)-based medical software and devices to ensure ongoing effectiveness and patient safety. The agency released a 20-page discussion paper explaining the need for a new framework, the tenets of a total product lifecycle (TPLC) approach to certification, and examples of potential real-world AI software modifications that may or may not be permitted under the proposed framework. The FDA is asking for comments and feedback from all parties to inform future decisions.

Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform for anatomy education. Currently enabled on Microsoft's HoloLens AR technology and Magic Leap's spatial computing device, Magic Leap One, AnatomyX offers any member of a large university or medical institution an enterprise-grade learning platform for the study of human anatomy, physiology and pathology.

April 2, 2019 — A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander cardiopulmonary resuscitation (CPR) nearly doubled, and compression-only (or Hands-Only CPR) increased six-fold over an 18-year period.

How to reduce radiation dose in cardiac CT.

April 1, 2019 — Here is a checklist of dose-sparing practices for coronary computed tomography angiography (CCTA) imaging. This list was included in a new 2018 consensus document to guide the optimal use of ionizing radiation in cardiovascular imaging.[1] 
 

AIMed Radiology - Artificial Intelligence in Medicine

The 2019 AIMed Radiology conference in June in Chicago is aimed at those interested in the use of artificial intelligence (AI) and deep learning in advanced medical imaging. The conference also allows attendees to experience the future of radiology using augmented and virtual reality and to understand the future of medical education and training with AI. 

The conference is June 18-19, 2019, at the Ritz-Carlton Chicago. The event is expected to draw 1,800 attendees, 350 speakers and about 1,500 companies, including start-ups and some of the key players bringing AI into Healthcare.

The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.

April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of March 2019. This is based on the website’s 276,315 pageviews for the month:
 
 

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, according to new research. The findings were presented at the American College of Cardiology’s (ACC) 68th Annual Scientific Session, March 16-18 in New Orleans.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now